INTERNATIONAL PATENT: WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY, 武汉人福创新药物研发中心有限公司 FILES APPLICATION FOR "COMPOUND ACTING AS MRGPRX2 ANTAGONIST AND PREPARATION METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-03-08

GENEVA, March 8 -- WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY (Room 705-2, Building C7, No. 666 Gaoxin Road, Wuhan East Lake High-Tech Development Zone,Wuhan, Hubei 430075), 武汉人福创新药物研发中心有限公司 (中国湖北省武汉市东湖新技术开发区高新大道666号C7栋705-2室) filed a patent application (PCT/CN2024/114326) for "COMPOUND ACTING AS MRGPRX2 ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF" on Aug 23, 2024. With publication no. WO/2025/044946, the details related...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY, 武汉人福创新药物研发中心有限公司 FILES APPLICATION FOR "COMPOUND ACTING AS MRGPRX2 ANTAGONIST AND PREPARATION METHOD THEREFOR AND USE THEREOF"